RAS Inhibitors News

News

Boehringer Ingelheim, anti-hypertensi | Boehringer Ingelheim single combination of telmisartan and
www.pharmaasia.com | Feb 2, 2012
Boehringer Ingelheim has released a new anti-hypertensive drug (TWYNSTA) containing a unique combination of telmisartan and amlodipine. Very often, hypertension sufferers take up to four drugs to reach an acceptable blood pressure (BP) more effectively. The single-pill combination drug is taken

Blood Pressure Drug Shows Some Muscle - 05/11/2011
www.hopkinsmedicine.org | Jan 27, 2012
Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | PRLog
www.prlog.org | Nov 10, 2011
Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The HF Therapeutics Market Shows Significant Growth Until 2018 - PR11720407

Takeda Receives Positive CHMP Opinion in Europe for EdarbiTM (azilsartan medoxomil) for the
www.takeda.com | Oct 5, 2011
London, UK, September 23 and Osaka, Japan, September 26 – Takeda Pharmaceutical Company Limited (Takeda) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Edarbi^TM (azilsartan medoxomil,

Blood pressure drug shows some muscle
www.eurekalert.org | May 12, 2011
Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

ACE Inhibitors Seem to Raise Risk of Breast Cancer Recurrence, University of California, Los
www.biospace.com | Apr 22, 2011
University of California, Los Angeles (UCLA) -- ACE inhibitors, commonly used to control high blood pressure and heart failure in women, may also be associated with an increased risk of breast cancer recurrence in women, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer

Medical News: ACE Inhibitor May Trigger Breast Ca Recurrence - in Oncology/Hematology, Breast
www.medpagetoday.com | Apr 22, 2011
Breast cancer survivors had more than a 50% increase in the risk of recurrence if they were taking ACE inhibitors, a retrospective analysis of a large cohort study showed.

ABB investment sharpens solar focus
www.abb.com | Mar 16, 2011
Zurich, Switzerland, March 16, 2011 – ABB, the leading power and automation technology group, has agreed to buy a 35 percent stake in Novatec Solar (formerly Novatec Biosol), an innovative Concentrated Solar Power (CSP) technology company based in Karlsruhe, Germany.

Urgent recall of Perindopril blister packs
www.healthinsite.gov.au | Dec 14, 2010
The Therapeutic Goods Administration (TGA) is undertaking an urgent consumer-level recall of specified batches of APO-Perindopril 2mg tablets in blister packs of 30 tablets, because some cartons of 2mg tablets may contain 8mg tablets.

Angiotensin-receptor blockade, cancer, and concerns : The Lancet Oncology
www.thelancet.com | Sep 14, 2010
Angiotensin-receptor blockade, cancer, and concerns. By - Michael Böhm, Ulrich Laufs, Michael Pfreundschuh